NL-OMON48592已完成2 期
Guselkumab for hidradenitis suppurativa, a mode of action study. - HiGUS trial
niversitair Medisch Centrum0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Adult (* 18 years of age) male or female patients with moderate to severe HS (i.e. a PGA of 3 or more) with a treatment history of at least one systemic anti-in*ammatory / immunosuppressive agent; HS diagnosis of at least 1 year; minimum of two anatomical locations with HS lesions and a minimum of 4 active abscesses and/or inflammatory nodules (AN).
排除标准
- •Contra-indication for guselkumab; previous use of guselkumab; use of treatment with biologics or any immunosuppressives for HS in the last 3 months prior to randomization; presence of other uncontrolled major disease; pregnant or lactating women.
研究者
相似试验
进行中（未招募）
1 期
Guselkumab for the treatment of hidradenitis suppurativaHidradenitis suppurativaEUCTR2018-002978-52-NLniversitair Medisch Centrum Groningen20
已完成
2 期
Guselkumab for Hidradenitis Suppurativa, a Mode of Action Study.Hidradenitis SuppurativaNCT04061395University Medical Center Groningen20
已完成
不适用
Treatment of Hidradenitis Suppurativa with a blue light (415 nm) and red light(633 nm) combination PDTacne inversa10014982hidradenitis suppurativaNL-OMON31302Catharina-ziekenhuis11
尚未招募
不适用
Gubenkangmin Granules for chronic spontaneous urticaria: a randomised double-blind, placebo-controlled clinical trialChronic urticariaITMCTR1900002367Guangdong Provincial Hospital of Chinese Medicine
招募中
2 期
Efficacy of Guselkumab in Treating Hailey Hailey DiseaseHailey Hailey DiseaseNCT06651489Yale University10